Core One Labs Inc.: Core One Labs' Prepares for Commercial Production of API-Grade Psilocybin; Plans Initial Production Run at GMP Facility in January

VANCOUVER, BC / ACCESSWIRE / November 18, 2022 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce the initial production run

Related Keywords

Canada ,Vancouver ,British Columbia ,Canadians ,Canadian ,Joel Shacker ,Health Canada Special Access Program ,Biosciences Inc ,Core One Labs Inc ,Akome Biotech Ltd ,Canadian Psychedelic Association ,Vocan Biotechnologies Inc ,Nanos Research ,Health Canada ,Canadian Securities Exchange ,Company Or Core ,Core One Labs Inc View ,Core One Labs ,Core One ,Special Access Program ,One Labs ,Awakened Biosciences Inc ,Disclaimer Statement ,Controlled Drugs ,Substances Act ,Core ,Labs ,Repares ,Commercial ,Production ,Rade ,Silocybin ,Plans ,Nitial ,Facility ,January ,